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Abstract
Purpose Chemotherapy can affect smell and taste function. This has never been investigated in childhood cancer patients during
chemotherapy. The objective of this study was to determine whether psychophysical smell and taste tests are suitable for children
with cancer. Taste and smell function, fungiform papillae density, and eating behavior weremeasured before (T1) and after (T2) a
cycle of chemotherapy and compared with healthy controls.
Methods Thirty-one childhood cancer patients treated for a hematological, solid, or brain malignancy (median age 12 years, 16
girls), and 24 healthy controls (median age: 11 years, 10 girls) participated. Smell function was measured using Sniffin’ Sticks,
including a threshold, discrimination, and identification test. Taste Strips were used to determine recognition thresholds for sweet,
sour, salty, and bitter taste. Papillae density was investigated by counting the fungiform papillae of the anterior tongue. Eating
behavior was assessed using the Behavioral Pediatrics Feeding Assessment Scale (BPFAS).
Results Smell and taste function could be investigated in more than 90% of the patients, while fungiform papillae density could
be determined in 61% of the patients. A significant difference in smell threshold was found between patients and controls (p =
0.001), showing lower thresholds in patients. In patients, sweet taste (p < 0.001), bitter taste (p = 0.028), and total taste function
(p = 0.004) were significantly different after a cycle of chemotherapy, with higher scores at T2.
Conclusion The assessment of smell, taste, and fungiform papillae density is feasible in children with cancer. Results of the
current study suggest that smell and taste sensitivity increased in children with cancer.
Keywords Smell . Taste . Childhood cancer . Chemotherapy
Introduction
Childhood cancer survival rates have markedly improved in
recent decades [1]. Increased survival can be attributed to
providing more intensive therapies. However, as a result, al-
most all such children suffer from bothersome or severe
treatment-related side effects [2]. Nausea, vomiting, and loss
of appetite are well-known side effects among childhood can-
cer patients, interfering with food intake [3]. Taste changes
have been found to be the third most common bothersome
symptom (prevalence 60.3%) [2]. These changes are an often
overlooked side effect contributing to inadequate food intake,
which in turn affects nutritional status [4]. Poor nutritional
status in children with cancer is associated with increased
infections, poor survival, and impaired health-related quality
of life [5, 6].
Studies investigating changes in smell and taste among
childhood cancer patients are rare. Skolin and colleagues
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found that children with cancer undergoing chemotherapy had
significant lower scores for bitter taste and made more taste
recognition errors compared with controls [7]. However, this
cross-sectional study was heterogeneous regarding chemo-
therapy (i.e., patients receiving doxorubicin, methotrexate,
ifosfamide, cytarabine, procarbazine, dacarbazine, cisplatin,
or cyclophosphamide per protocol depending on diagnosis
and treatment phase), and only ten patients (median age
14.5 years) underwent a taste test. Qualitative studies indicat-
ed that changes in taste were the predominant cause of eating
problems and altered food preferences in children with cancer,
although specific food choices were highly variable [7, 8].
Changes in taste are often accompanied by changes in smell
function. This has been found in adult patients undergoing
various chemotherapy regimens (e.g., anthracycline, taxane,
platinum containing) but has not been studied in childhood
cancer patients during chemotherapy [9]. Only one study eval-
uated both smell and taste function in pediatric patients (n =
10) after bone marrow transplantation, but not during chemo-
therapy [10]. As current evidence comes from small studies
and lack the assessment of smell function in childhood cancer
patients during chemotherapy, prospective studies are needed
to measure smell and taste function in children with cancer
during chemotherapy.
Before investigating smell and taste changes in childhood
cancer patients extensively, it must be considered whether
psychophysical smell and taste assessments can be obtained
without unpleasant side effects. For example, if children with
cancer are rather sensitive to odors, which are regularly seen in
adult patients, they might experience nausea when certain
odors are presented [11]. Therefore, this study aimed to ex-
amine whether measurements of smell, taste, and fungiform
papillae density are feasible (i.e., completed by more than
60% of the patients) in children with cancer and if those tests
require adjustments. Furthermore, smell and taste function,
fungiform papillae density, and eating behavior were evaluat-
ed during chemotherapy (i.e., before and after a cycle) and
compared with healthy controls, results of which contribute
to a burgeoning understanding of smell and taste changes and
their consequences in children with cancer.
Methods
Participants
This study was performed at the Princess Máxima Center for
Pediatric Oncology in Utrecht, the Netherlands. Eligible pa-
tients were children diagnosed with a hematological, solid, or
brain malignancy, currently treated with chemotherapy.
Treatment regimens supplied during the study period can be
found in Table 1.
Patients were compared to healthy controls, matched by
age and gender. Controls were recruited among siblings and
friends of the patients. Participants were eligible for participa-
tion if they were between 6 and 18 years and able to under-
stand Dutch. Exclusion criteria were as follows: isolated con-
genital anosmia (ICA) or a self-reported allergy to quinine.
Procedure and feasibility assessment
Patients were measured twice whereas controls were measured
only once. A measurement was postponed in the case of severe
oral mucositis or having a cold. During the first measurement in
patients (T1), which was performed at day one of a cycle of
chemotherapy somewhere during treatment protocol, feasibility
of the tests was assessed. A test was considered feasible if at
least 60% of the patients could complete the test without un-
pleasant side effects. Additionally, patients were asked to rate
the tests by using smileys regarding the following topics: fun,
difficulty level, concentration, and time duration.
If the first measurement in patients was considered viable, a
second measurement (T2) was performed to assess potential
changes in smell and taste within a cycle of chemotherapy.
When a patient was admitted to the hospital for at least 4 days,
the second measurement was taken on the last day of admis-
sion. In case of a shorter hospital stay, the second measure-
ment was performed on the first day of the following chemo-
therapy cycle (usually 21 days later).
Measurements
Smell function
Sniffin’ Sticks (Burghart, Wedel, Germany) were used to de-
termine smell function [12]. This test comprises three parts:
odor threshold (THR), discrimination (DIS), and identifica-
tion (ID). All odorants are presented in pen-like odor dispens-
ing devices, which are positioned 2 cm in front of the patient’s
nostrils for approximately 3 sec. For the THR-test, a modified
set of eight dilutions of phenyl ethyl alcohol (PEA; rose-like
smell) was used [13]. Each time, three pens, of which one
contained PEA and two contained a non-odorous solvent,
were presented to the blindfolded participant. The participant
had to distinguish the odor-containing pen in a staircase up-
down procedure by starting with the lowest concentration of
PEA. Reversal of the staircase was triggered by two correct or
one false identification until seven reversals were obtained or
until five reversals if attentiveness waned. The average of the
last four reversal points was used as threshold score and
ranged between 1 and 15. For the DIS-test, 16 triplets, con-
taining two equal odorants and one different odorant, were
presented in a randomized order. Participants, who were
blindfolded, had to determine which pen smelled differently.
ID was assessed by presenting sixteen common odorants, and
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participants had to identify these odorants by using a four-
choice task. For DIS and ID, a correct response resulted in
one point and scores range between 0 and 16.
Taste function
Filter-paper strips (Taste Strips, Burghart, Wedel, Germany) with
impregnated concentrations of sweet, sour, salty, and bitter were
used to determine taste recognition thresholds [14]. Each time,
one of four concentrations of sweet taste (0.05, 0.1, 0.2, and 0.4 g/
ml sucrose), sour taste (0.05, 0.09, 0.165, and 0.3 g/ml citric acid),
salty taste (0.016, 0.04, 0.1, and 0.25 g/ml sodium chloride), or
bitter taste (0.0004, 0.0009, 0.0024, and 0.006 g/ml quinine
hydrochloride) was presented in an order of increasing concen-
trations. Before the test began, the highest concentration of each
taste was given to familiarize participants with the taste qualities.
Taste strips were placed on the middle of the tongue for whole-
mouth testing. Participants were then asked whether the per-
ceived taste was sweet, sour, salty, bitter, or tasteless. Scores for
each taste quality range from 0 to 4, and the total taste score was
derived by summing the scores of each taste quality (range 0–16).
Subjective smell, taste, and appetite
Participants were asked to self-assess their smell, taste, and
appetite on a 5-point Likert scale (1 “very bad” to 5 “very
Table 1 Characteristics of
childhood cancer patients and
healthy controls
Characteristics Patients (n = 31) Controls (n = 24) p value
Gender, female (n, %) 16 (51.6) 10 (41.7) 0.464
Age (median, range) 12 (7–17) 11 (6–18) 0.658
6–8 years (n, %) 7 (22.6) 5 (20.8)
9–14 years (n, %) 14 (45.2) 13 (54.2)
15–18 years (n, %) 10 (32.2) 6 (25.0)
Diagnosis




Brain tumor (n, %) 3 (9.7)
Medulloblastoma 3 (9.7)
Solid tumor (n, %) 12 (38.7)
Bone 9 (29.0)
Rhabdomyosarcoma 3 (9.7)
Chemotherapy regimen (n, %)*
Alkylating agentsa 14 (53.8)
Anthracyclinesb 7 (26.9)
Platinum agentsc 4 (15.4)




Intensity of Treatment Rating (ITR)
Moderate intensive (n, %) 11 (35.5)
Very intensive (n, %) 17 (54.8)
Most intensive (n, %) 3 (9.7)
ALL acute lymphoblastic leukemia, AML acute myeloid leukemia
* Provided chemotherapy between T1 and T2, n = 26






gAsparaginase, dactinomycin, dexamethasone, prednisone
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good”). In addition, participants rated their smell, taste, and
appetite (1 “much worse” to 5 “much better”) compared with
the start of chemotherapy (patients) or with the last month
(controls).
Fungiform papillae density
Fungiform papillae density was investigated by staining the
tongue with a 0.9% Brilliant Blue food dye (Pomona Aroma,
Hedel, the Netherlands), diluted to a concentration of 1:10 at
which fungiform papillae remain pink [15]. Participants were
asked to extend their tongue and secure it gently between their
teeth and lips. Subsequently, the tongue was dried with filter
paper, stained with blue food dye, and dried again. Then, a 15-
mm-diameter Whatman circular filter paper Grade 1 (GE
Healthcare Life Science, Chalfont St. Giles, UK) with a 6-
mm-diameter circular cut-out (area 0.283 cm2) was placed
on the anterior of the left side of the tongue, next to the midline
[16]. At least three close-up images of the tongue were taken
by a digital camera (Canon Powershot SX70 HS, Tokyo,
Japan). Afterwards, the clearest image was further investigat-
ed in Fiji, a distribution of ImageJ software (National
Institutes of Health, Bethesda, USA) [17]. The Denver
Papillae Protocol (DPP) was used for counting fungiform pa-
pillae [18].
Eating behavior
Eating behavior was assessed using the Behavioral Pediatrics
Feeding Assessment Scale (BPFAS) [19]. The BPFAS is a 35-
item parent-report questionnaire that consists of 25 items that
focus on the child’s eating behavior and 10 items that focus on
parents’ feeding strategies. For each statement, parents report-
ed how often the particular behavior occurred on a 5-point
Likert scale (1 “never” to 5 “always”). They were also asked
to indicate whether they believed that this behavior was prob-
lematic or not. Four scores are thus generated: Child
Behavior-Frequency (CBF) and Parent Behavior-Frequency
(PBF) (which refer to how often the specific child and parent
behavior occur) and Child Behavior-Problems (CBP) and
Parent Behavior-Problems (PBP) (which reflect the number
of behaviors seen as problematic). Higher scores indicate
more eating/feeding problems [20].
Treatment intensity
Treatment intensity was rated with the Intensity of Treatment
Rating scale (ITR-3), a psychometrically valid classification
of pediatric cancer treatment, into one of four levels ranging
from 1 “minimally invasive” (e.g., in case of stage 1 Wilm’s
tumor) to 4 “most invasive” (e.g., in case of a brain tumor with
treatment requiring HSCT) [21].
Statistical analysis
Descriptive statistics are presented as median with interquar-
tile range (IQR) or number of participants (N) with percentage
(%) for both groups. The Mann-Whitney U Test was used to
compare smell, taste, fungiform papillae density, and BPFAS
scores between controls and patients at T1. The Wilcoxon
signed-rank test was used to compare changes in smell, taste,
and fungiform papillae density between the two measure-
ments in patients. Spearman’s test was employed to investi-
gate correlations between taste function and fungiform papil-
lae density and taste function and eating behavior in patients at
T1. A 5% alpha level was used. Data analysis was performed
with IBM SPSS Statistics (version 25.0).
Results
Participant characteristics
Thirty-one patients and 24 healthy controls were included in
this study (Table 1). After the first measurement, five patients
left the study because they completed their treatment (n = 2),
continued treatment somewhere else (n = 1), or became too ill
(n = 2). Median time interval between T1 and T2 was 21 days
(IQR 14–37). Six patients underwent the second measurement
more than 37 days later due to postponed admissions or severe
complications.
Feasibility assessment in patients
Twenty-nine patients (94%) performed the THR-test, and for
the 23 of them (79%), a THR-score could be obtained after
seven reversals of the staircase. For the remaining six patients,
the THR-score was calculated after five reversals of the stair-
case as their attentiveness waned. For DIS and ID, 28 (90%)
and 30 (97%) patients could complete these tests, respectively.
Thirty patients (97%) finished the taste test. One DIS-test and
taste test were prematurely terminated due to nausea. For pa-
pillae density, six patients (19%) did not undergo the measure-
ment. Reasons for not participating in this test were as follows:
nausea/gagging (n = 2), anxiety/tension (n = 2), or logistical
reasons (n = 2). From the remaining 25 patients, six photos
were of insufficient quality to count the fungiform papillae.
Overall, fungiform papillae density could be calculated for 19
(61%) of the patients.
Concerning patients’ experiences, 81% reported that they
really liked the overall assessment and 84% reported that they
did not experience any problems concerning concentration.
Difficulty of the tests was qualified by 71% of the patients
as “a bit difficult.” In addition, 39% of the patients reported
time of the assessment as “long lasting.”
Support Care Cancer
Smell and taste function
Figure 1 shows smell function of the childhood cancer patients
and controls. A significant difference in smell threshold was
found between patients and controls (p = 0.001), showing
lower thresholds in patients. DIS and IDwere not significantly
different between the two groups. In patients, no significant
differences in smell function were found between the two
measurements.
Compared with controls, patients had a different sour taste
threshold (p = 0.042) (Fig. 2). Regarding the other taste qualities,
no significant differences were found between patients and con-
trols. In patients, sweet taste (p < 0.001), bitter taste (p = 0.028),
and total taste function (p = 0.004) were significantly different
after a cycle of chemotherapy, showing higher scores at T2.
Table 2 shows subjective smell, taste, and appetite of child-
hood cancer patients at T1. Twelve patients (39%) reported
changes in smell, and 11 patients (36%) reported taste chang-
es, reflecting both increased and decreased perceptions. In
addition, 24 patients (77%) reported alterations in appetite.
Fungiform papillae density
Fungiform papillae density was neither significantly different
between patients and controls, nor between the two measure-
ments in patients (Table 3). Fungiform papillae density was
not significantly correlated with taste function in children with
cancer.
Eating behavior
No significant differences were found in BPFAS scores and
the prevalence of eating disorders between patients and con-
trols (Table 4). In patients, the total taste function at T1 was
negatively correlated with PBF (r = − 0.402, p = 0.042),
meaning that a better taste function is associated with less
frequently reported “poor” feeding strategies. Additionally, a
difference in taste function (T1 vs T2; i.e., increased sensitiv-
ity in this case) was positively correlated with CBF (r = 0.469,
p = 0.037). Thus, increased taste function in children with
cancer was associated with eating disorders.
Fig. 1 Boxplots for the three different smell tests: odor threshold (a), odor
discrimination (b), and odor identification (c). The boxplots refer to the
median score (midpoint of the scores), the first quartile of the scores (Q1,
lower boundary of the box), and the third quartile of the scores (Q3, upper
boundary of the box). The range of the box represents the interquartile
range (IQR =Q3 –Q1), and the whiskers indicate what data points can be
considered outliers. The upper whisker extends to the most extreme score
no more than 1.5 times the IQR above Q3, and the lower whisker extends
to themost extreme score nomore than 1.5 times the IQR belowQ1. Note
that the data points represent individual scores and that these points were
slightly jittered to avoid overplotting
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Discussion
The present study has shown that assessing smell, taste, and
fungiform papillae density is feasible in children with cancer,
as more than 60% of the patients were able to complete the
tests. Although feasible, some adaptions are deemed neces-
sary regarding time duration and difficulty level of the tests.
Furthermore, we showed that taste function increased in child-
hood cancer patients during chemotherapy, especially for
sweet and bitter taste. Lower smell thresholds were found in
patients compared with healthy controls, which suggest that
both smell and taste sensitivity increased in children with
cancer.
Regarding smell function, a wide step method was used for
the threshold test to enhance concentration and reduce time of
investigation. This method has never been used in children but
has been shown reliable in adults [13]. Due to the size of our
control group, and its distribution across different age catego-
ries, it was not possible to compare the threshold scores with
those derived from a regularly used narrow step method [22].
Fig. 2 Boxplots for the “Taste Strips” test scores: sweet taste (a), salty taste (b), sour taste (c), bitter taste (d), and total score (e). Note that due to the
limited range of possible scores for the individual taste qualities (0–4; a–d), some boxes (and whiskers) appear constricted
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Still, the wide step method provides an advantage for thresh-
old testing in participants where time of investigation should
be kept as short as possible [13]. Although only one discrim-
ination test was prematurely terminated due to nausea, several
patients noted that they did not like the intensity and large
number of odorants either. Concerning odor identification,
children were often not familiar with some of the odorants
(e.g., turpentine, apple) from the odor identification test.
This finding is consistent with a study among German chil-
dren [23]. The Universal Sniff Test, a recently developed in-
ternational odor identification test for children, will be more
suitable as odorants are selected on familiarity [24]. This test is
now commercially available, including normative values for
children aged 6–17 years [22].
As smell thresholds are less influenced by age, contrib-
ute to a large extent to the diagnosis of smell loss, and seem
affected the most in our study population, the assessment of
smell function in children with cancer should include at
least an odor threshold test [25, 26]. However, the assess-
ment of several components of smell function, instead of a
single component, is preferred. Therefore, a suitable odor
identification task for children, such as the Universal Sniff
Test, should be added. Odor discrimination does not seem
to have much added value in children with cancer, and
child-friendly tasks are lacking. Removing this task will
save at least 10 min.
Investigating taste function and papillae density can be
considered feasible, although the assessment of papillae den-
sity was more problematic in children with cancer. The main
obstacle was not the measurement, which relatively few chil-
dren disliked, but rather obtaining a proper photograph of the
tongue. Photographs regularly failed due to movement of the
tongue or being taken in poorly lit rooms. Sometimes, fungi-
form papillae were invisible because of a white layer on the
surface of the tongue. The so-called oral thrush, or oral can-
didiasis, is common among people with a weakened immune
system [27]. In addition, papillae density was not significantly
different between the groups nor correlated with taste function
in patients. Although feasible, the limitations and current re-
sults do not warrant further investigation of fungiform papillae
density in children with cancer. Practical issues need to be
overcome first to reduce the burden on children with cancer.
Table 2 Subjective smell, taste,
and appetite among childhood
cancer patients at T1 (n = 31).
Rating Number of patients (%) Changes since start chemotherapy Number of patients (%)
Smell
Very good 8 (25.8) Much better 2 (6.4)
Good 19 (61.3) Better 6 (19.4)
Moderate 4 (12.9) Unchanged 19 (61.3)
Bad 0 (0.0) Worse 4 (12.9)
Very bad 0 (0.0) Much worse 0 (0.0)
Taste
Very good 6 (19.4) Much better 1 (3.2)
Good 20 (64.5) Better 4 (12.9)
Moderate 3 (9.7) Unchanged 20 (64.5)
Bad 2 (6.4) Worse 6 (19.4)
Very bad 0 (0.0) Much worse 0 (0.0)
Appetite
Very good 8 (25.8) Much better 0 (0.0)
Good 12 (38.7) Better 11 (35.5)
Moderate 6 (19.4) Unchanged 7 (22.6)
Bad 3 (9.7) Worse 10 (32.2)
Very bad 2 (6.4) Much worse 3 (9.7)
Table 3 Median scores (IQR) of
fungiform papillae in childhood









Number of papillae 15.0 (12.5–24.0) 20.0 (15.0–28.0) 20.5 (17.8–25.8) 0.327
Papillae density (cm²) 53.1 (44.2–84.9) 70.7 (53.1–99.0) 72.5 (62.8–91.1) 0.294
IQR interquartile range
*p value between T1 and T2 within patients
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Results of our study seem to indicate that smell function
sensitizes in childrenwith cancer, showing lower smell thresh-
olds compared with controls. Smell function did not change
significantly after a cycle of chemotherapy in patients. Our
findings are in contrast with those of previous studies who
examined adults receiving chemotherapy. For example, wom-
en undergoing chemotherapy for breast cancer or gynecolog-
ical malignancies showed increased smell thresholds during
chemotherapy [9]. In addition, men undergoing chemotherapy
for testicular cancer showed no changes in smell function [28].
Although there was no measurement before diagnosis, and it
cannot be ruled out that lower smell thresholds were already
present before diagnosis, several children with cancer (n = 8)
reported a better or much better smell perception since the start
of chemotherapy. This may well be an underestimation.
Increased smell sensitivity was typically judged as negative.
Possibly, some children conflated their evaluation of their
altered sense of smell with their altered smell sensitivity lead-
ing them to rate their sense of smell as “worse” after chemo-
therapy. Future research on subjective smell and taste sensi-
tivity in children with cancer requires more careful instruction
and phrasing of questions.
The current study showed increased sweet, bitter, and
total taste function after a cycle of chemotherapy. So far,
evidence regarding smell and taste function in childhood
cancer patients during chemotherapy is limited to cross-
sectional studies with small sizes. Those studies generally
show reduced taste perception for all taste qualities, or
bitter taste only, in children with cancer compared with
healthy controls [7, 29]. When reviewing prospective
studies among adults receiving chemotherapy, changes
in sweet taste and, to a lesser extent, bitter taste seem
more common than changes in salt or sour perception
[30]. However, taste changes in the current subset of
childhood cancer patients were characterized by increased
perception of sweet and bitter taste, while adults generally
experience a decreased perception of these taste qualities
during chemotherapy. Maybe other pathways are involved
in children compared with adults.
The etiology of smell and taste changes during chemother-
apy is not fully understood. In general, damage to sensory
receptor cells and abnormal neuronal activity are thought to
be the major cause of these distortions [31]. Smell and taste
receptor cells have high turnover rates, as do cancer cells, and
particularly rapidly dividing cells are affected by chemother-
apy. With respect to specific chemotherapeutic substances,
drugs such as methotrexate, vincristine, cisplatin, carboplatin,
doxorubicin, cyclophosphamide, 6-mercaptopurine, and 5-
fluorouracil all seem to be associated with taste changes in
adults but not necessarily with smell changes [32]. Taste
changes may be also related to oral mucositis, poor oral hy-
giene, infections, or a dry mouth. In addition, it is presumed
that cancer-related inflammation can trigger apoptosis of the
taste bud cells through cytokine signaling pathways, thereby
contributing to the development of taste disorders [33]. An
enhanced ability to smell during chemotherapy, potentially
resulting in food aversions and nausea, might be a strength-
ened defense mechanism of the sensory organ to avoid inges-
tion of potentially harmful substances into the body [34].
However, many questions remain regarding smell and taste
changes during chemotherapy.
Taste function was correlated with eating behavior and
feeding strategies in children with cancer. This is in line
with qualitative studies that already highlighted the influ-
ence of taste changes on food preferences and eating be-
havior [7, 8, 35]. Since eating behavior and food prefer-
ences are still developing in children, and are strongly
influenced by the chemical senses, it is suggested that
the impact of smell and taste changes in the long term
could be large as well [36, 37]. To prevent children with
cancer from inadequate food intake and bad dietary habits
due to this phenomenon, longitudinal studies are needed
to identify the course of smell and taste changes and its
consequences regarding food intake and eating behavior
during and after chemotherapy.
This study aimed to investigate feasibility of smell,
taste, and papillae density assessment in children with
cancer. Therefore, the current results regarding smell and
Table 4 Comparisons of BPFAS
scores across childhood cancer
patients and healthy controls
Patients (n = 26) Controls (n = 20)
Median (IQR) N disorder (%) Median (IQR) N disorder (%)
Child Behavior-Frequency (CBF) 43.0 (38.5–47.3) 3 (11.5) 37.0 (34.3–45.8) 2 (10.0)
Child Behavior-Problem (CBP) 0.0 (0.0–0.8)a 3 (12.5) 0.0 (0.0–0.0)b 0 (0.0)
Parent Behavior-Frequency (PBF) 16.0 (13.0–18.0) 3 (11.5) 14.0 (12.0–16.0) 0 (0.0)
Parent Behavior-Problem (PBP) 0.0 (0.0–0.0)a 3 (12.5) 0.0 (0.0–0.0)b 1 (5.9)
IQR interquartile range
a n = 24
b n = 17
Support Care Cancer
taste function do not allow for strong conclusions and
should be considered tentative. Even if it is the largest
study to date, the size of the current study is small, lacks
a measurement at diagnosis, and varies in time intervals
between measurements. Nevertheless, the prospective
study design and control group make the results of this
feasibility study already useful for a burgeoning under-
standing of smell and taste changes in children with can-
cer during chemotherapy.
In conclusion, the assessment of smell and taste function
and fungiform papillae density is feasible in children with
cancer. Future longitudinal studies should focus on smell
(threshold and identification) and taste function in children
with cancer, whereas the assessment of fungiform papillae
density should be omitted. In addition, results of the current
study suggest a remarkable increased smell and taste sensitiv-
ity in children with cancer, which was an unexpected finding
and requires further investigation.
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